Real-world impact of dupilumab on asthma disease burden in Japan: The CROSSROAD study.

MLA

Fukunaga, Koichi, et al. “Real-World Impact of Dupilumab on Asthma Disease Burden in Japan: The CROSSROAD Study.” Allergology International, vol. 72, no. 4, Oct. 2023, pp. 537–44. EBSCOhost, https://doi.org/10.1016/j.alit.2023.04.001.

APA

Fukunaga, K., Tagaya, E., Ishida, M., Sunaga, Y., Koshiba, R., & Yokoyama, A. (2023). Real-world impact of dupilumab on asthma disease burden in Japan: The CROSSROAD study. Allergology International, 72(4), 537–544. https://doi.org/10.1016/j.alit.2023.04.001

Chicago

Fukunaga, Koichi, Etsuko Tagaya, Masato Ishida, Yoshinori Sunaga, Ryuji Koshiba, and Akihito Yokoyama. 2023. “Real-World Impact of Dupilumab on Asthma Disease Burden in Japan: The CROSSROAD Study.” Allergology International 72 (4): 537–44. doi:10.1016/j.alit.2023.04.001.